PODD - Insulet Corporation
NEXT EARNINGS:
May 14, 2026
EPS Est: $1.20
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$357.25
DETAILS
HIGH:
$435.00
LOW:
$286.00
MEDIAN:
$355.00
CONSENSUS:
$357.25
UPSIDE:
45.67%
Market Cap:
17.26B
Volume:
1,210,482
Avg Volume:
871,053
52 Week Range:
230.05-354.88
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.42
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
3,900
IPO Date:
2007-05-15
EPS (TTM):
3.51
P/E Ratio:
80.92
Revenue (TTM):
2.71B
Total Assets:
3.19B
Total Debt:
1.05B
Cash & Equiv:
716.10M
Rev Growth (5Y):
24.5%
EPS Growth (5Y):
99.9%
FCF Growth (5Y):
N/A
ROCE:
18.9%
Debt/Equity:
0.69
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-18 | $1.44 | $1.48 | -2.7% | $783.8M | $728.7M | +7.6% |
| 2025-11-06 | $1.24 | $1.14 | +8.8% | $706.3M | $678.4M | +4.1% |
| 2025-08-07 | $1.17 | $0.92 | +27.2% | $649.1M | $614.2M | +5.7% |
| 2025-05-08 | $1.02 | $0.79 | +29.1% | $569.0M | $543.3M | +4.7% |
| 2025-02-20 | $1.15 | $1.00 | +15.0% | $597.5M | $582.5M | +2.6% |
| 2024-11-07 | $0.90 | $0.76 | +18.4% | $372.6M | $519.5M | -28.3% |
| 2024-08-08 | $0.55 | $0.56 | -2.5% | $488.5M | $488.0M | +0.1% |
| 2024-05-09 | $0.73 | $0.39 | +87.2% | $441.7M | $424.1M | +4.2% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.71B | 2.07B | 1.70B | 1.31B | 1.10B | 904.40M | 738.20M | 563.82M | 463.77M | 366.99M | 263.89M | 288.72M |
| Net Income | 247.10M | 418.30M | 206.30M | 4.60M | 16.80M | 6.80M | 11.60M | 3.29M | (26.83M) | (28.88M) | (73.52M) | (51.50M) |
| EPS | 3.51 | 5.97 | 2.96 | 0.07 | 0.25 | 0.11 | 0.19 | 0.06 | -0.46 | -0.51 | -1.29 | -0.93 |
| Total Assets | 3.19B | 3.09B | 2.59B | 2.25B | 2.05B | 1.87B | 1.14B | 928.74M | 816.74M | 456.65M | 275.13M | 302.16M |
| Total Debt | 1.05B | 1.42B | 1.45B | 1.43B | 1.29B | 1.08B | 905.90M | 591.98M | 566.17M | 333.04M | 177.49M | 174.64M |
| Cash & Equivalents | 716.10M | 953.40M | 650.70M | 623.90M | 791.60M | 907.20M | 203.70M | 113.91M | 272.58M | 137.17M | 122.67M | 151.19M |
| Operating Cash Flow | 569.30M | 430.30M | 145.70M | 119.00M | (68.10M) | 84.00M | 98.40M | 35.90M | 41.30M | 15.91M | (12.55M) | 8.92M |
| Free Cash Flow | 377.70M | 305.40M | 70.10M | (38.30M) | (190.80M) | (82.50M) | (72.50M) | (126.45M) | (36.02M) | (6.20M) | (23.16M) | (2.57M) |
| FCF per Share | 5.37 | 4.36 | 1.01 | -0.55 | -2.82 | -1.27 | -1.20 | -2.15 | -0.62 | -0.11 | -0.41 | -0.05 |
| Book Value | 1.52B | 1.21B | 732.70M | 476.40M | 556.30M | 603.60M | 75.90M | 212.10M | 158.52M | 63.15M | 34.05M | 83.83M |
| Cash & ST Investments | 716.10M | 953.40M | 704.20M | 674.70M | 791.60M | 947.60M | 376.10M | 288.95M | 440.06M | 298.57M | 122.67M | 151.19M |
| ROC Equity | 0.16 | 0.35 | 0.28 | 0.01 | 0.03 | 0.01 | 0.15 | 0.02 | -0.17 | -0.46 | -2.16 | -0.61 |